ArticleClinical, cosmetic and investigational dermatology2026
Depression and Anxiety in Patients with Rosacea and Their Impact on Quality of Life: A Cross-Sectional Study.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neuro-immune-vascular interactions in rosacea and hypertension: a mechanistic review.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Rosacea is a long-term skin condition that causes redness and irritation on the face and is often accompanied by emotional challenges such as anxiety and depression. This study aimed to investigate the prevalence of depression and anxiety in patients with rosacea and examine their impact on quality of life, aiming to provide a basis for comprehensive clinical evaluation of the physical and psychological harm caused by the disease and for targeted treatments. Methods: A total of 209 patients with rosacea who received treatment and the control group comprised 163 patients with isolated plantar warts. Depression, anxiety, and quality of life were assessed using the Self-Rating Depression Scale (SDS), Self-Rating Anxiety Scale (SAS), and Dermatology Life Quality Index (DLQI). Group differences were made using Results: Patients with rosacea had significantly higher mean scores for depression, anxiety, and quality of life impairment than controls (P < 0.05). The proportions of patients with mild to severe depression, anxiety, and significant quality of life impairment were also higher in the rosacea group, with statistically significant differences (P < 0.05). Among patients with rosacea, both mild and moderate-to-severe depression and anxiety were associated with an increased risk of severe quality of life impairment (P < 0.05). Furthermore, joint effect analysis showed that patients with both depression and anxiety had a markedly higher risk of severe quality of life impairment compared with those without either condition (P < 0.05). Conclusion: Rosacea is strongly associated with depression and anxiety, whose coexistence confers the greatest risk of quality-of-life impairment. Incorporating psychological screening and care into routine management may improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.